Programme – Day 1

DAY 1

Central and South-East European Melanoma Expert Group (CSEEMEG) regional meeting.


PRVI DAN / DAY 1 26.11.2020. 
09.30 - 09.40 Opening of the meeting Prof. dr Mirna Šitum,

Doc. dr Davorin Herceg dr.med,

Prof. dr Lidija Kandolf Sekulović
09.40 - 10.10Opening lecture: Melanoma 2020: State of the art in the treatment of
metastatic disease
Prof. dr med. Axel Hauschild (Germany)
10.10 - 10.25 Discussion
10.25 - 11.30 Special clinical scenarios and best treatment options
(with discussion)
Moderators:

Prof. dr med. Axel Hauschild,

Prof. dr Lidija Kandolf Sekulović,

Doc. dr. Davorin Herceg dr.med,

Assoc. Professor Janja Ocvirk
10.30 - 10.40Patient with oligometastatic disease. Luka Simetić (Croatia)Luka Simetić (Croatia)
10.40 - 10.50Patient with progression to targeted therapyProf. dr Željko Mijušković (Serbia)
10.50 - 11.00BRAFwt metastatic melanoma with progression on anti-PD1 monotherapyProf. dr Janja Ocvirk (Slovenia)
11.00 - 11.10Patient with asymptomatic brain metastasesDoc. dr Davorin Herceg (Croatia)
11.10 - 11.20Patient with symptomatic brain metastasesPrim. dr sc. Nina Dabelić (Croatia)
11.20 - 11.30Discussion
11.30 - 12.00

Satellite symposium Novartis

12.00 - 13.00

Satellite symposium MSD

13.00 - 14.30Special clinical scenarios and best treatment options (with discussion)Moderators:

Prof.dr Nada Babović

Prof. dr Janja Ocvirk

Academician Prof. dr Mirna Šitum
13.05 - 13.09Patient with bone metastasesDr sc. med Vladimir Vidović (Serbia)
13.09 - 13.14Patient with progression on second-line treatmentDr Aleksandar Popović (Serbia)
13.14 - 13.24Patients with autoimmune diseases and chronic infections Dr Dobrica Nerić (Serbia)
13.24 - 13.34Patient with grade 3 adverse reaction to immunotherapy. Dr Suzana Matković (Serbia)
13.34 - 13.43Patient with grade 3 cutaneous toxicity to targeted therapy:
Stevens-Johnson syndrome and TEN.
Doc. dr Tatjana Radević (Serbia)
13.43 - 14.53Patient with grade 3 cutaneous toxicity to immunotherapyProf. dr Dušan Škiljević (Serbia)
13.53 - 14.00Patient with vitiligoPrim. dr sc. Daška Štulhofer Buzina (Croatia)
14.00 - 14.10Patient with changing melanocytic lesions during treatment. Doc. dr sc. Marija Buljan (Croatia)
14.10 - 14.30DiscussionAll participants
14.30 - 15.40

Satellite symposium Bristol Myers Squibb

15.40 - 16.00Pause
16.00 - 17.00EuMelaReg and CSEEREG melanoma treatment registries - first results

Moderators:

Academician prof. dr. Mirna Šitum,

Doc. dr. Davorin Herceg,

Prof. dr Lidija Kandolf Sekulović
16.00 - 16.15The EuMelaReg treatment registryProf. dr Michael Weichenthal (Germany)
16.15 - 16.30CSEEREG: review of the registryAcademician prof. dr. Mirna Šitum (Croatia)
16.30 - 16.50Treatment and outcomes in stage III and stage IV disease: first results from CSEEREGDoc. dr. Davorin Herceg (Croatia) and Prof. dr Lidija Kandolf Sekulović
16.50 - 17.00ConclusionsAll participants